Brainstorm Cell Therapeutics Inc. BCLI
Set alert
0.83 USD -0.03 -4.00%
As of Nov 2, 3:24 PM ET
0.8108 Day range 0.8282
0.46 52-week range 1.69
- YTD
- +50.13%
- 1 year
- +27.03%
- Open
- 0.8282
- Prev close
- 0.8601
- Mkt cap
- 9.11M
- Vol
- 367
- Avg vol
- 21.79K
- EPS
- -0.93
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.8108
- High
- 0.8282
- Forward P/E
- -0.91
- Beta
- 0.39
- Short ratio
- 1.25
- Inst. own
- 13.90%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.70
- 200-d avg
- 4.88
- 1y target
- 23.45
Analyst view
Consensus: buy
Buy
Price target (mean) 23.45 +2740.0% upside
Now 0.8257
- Target (low)
- 10.00
- Target (mean)
- 23.45
- Target (high)
- 36.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy1
- Buy0
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
- 2 months ago 1
- 3 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.27 | -0.27 – -0.27 | -1.50 | +82.0% | 0 | 0.0% | 1 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | -2.10 | -2.10 – -2.10 | -7.62 | +72.4% | 0 | 0.0% | 1 |
| Next year | -1.59 | -1.65 – -1.52 | -2.10 | +24.5% | 0 | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 11, 2024 | Maxim Group | Upgrade | Hold | Buy |
| Sep 28, 2023 | Maxim Group | Downgrade | Buy | Hold |
| Mar 31, 2023 | Maxim Group | Maintained | — | Buy |
| Feb 5, 2021 | Maxim Group | Upgrade | Hold | Buy |
| May 15, 2018 | HC Wainwright & Co. | Initiated | — | Buy |
| Aug 17, 2017 | Maxim Group | Maintained | — | Buy |